The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Open accessAbstract
The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obesity and its associated insulin resistance are associated with basal and stimulated hyperinsulinaemia [10, 68, 91, 92].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Somogyi, M. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43098-0 · Cited by 1,788
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 819 · cited 1×
“(24) and Cerasi and Luft (25) that insulin secretion is impaired in diabetes mellitus.”
BackgroundNew Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Promotion of Insulin Secretion by Glucagon
Samols, E., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90761-0 · Cited by 521
Intestinal Factors in the Control of Insulin Secretion
McIntyre, N., Holdsworth, C. D., & Turner, D. S. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1317 · Cited by 382
THE PLASMA INSULIN RESPONSE TO GLUCOSE INFUSION IN HEALTHY SUBJECTS AND IN DIABETES MELLITUS
Cerasi, E., & Luft, R. (1967) · Acta Endocrinologica · doi:10.1530/acta.0.0550278 · Cited by 371
Perley, M., & Kipnis, D. M. (1966) · Diabetes · doi:10.2337/diab.15.12.867 · Cited by 330
Self-citationYalow, R. S., & Berson, S. A. (1960) · Diabetes · doi:10.2337/diab.9.4.254 · Cited by 330
PLASMA INSULIN AND GROWTH HORMONE LEVELS IN OBESITY AND DIABETES
Yalow, R. S., Glick, S. M., Roth, J., & Berson, S. A. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34803.x · Cited by 199
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 914
Therapeutic Potential of Dipeptidyl Peptidase-IV Inhibitors in Patients With Diabetes Mellitus
Moore, K. B., & Saudek, C. D. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3180ed42dc · Cited by 15
Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man
Sarson, D. L., Kopelman, P. G., Besterman, H. S., Pilkington, T. R. E., & Bloom, S. R. (1983) · Diabetologia · doi:10.1007/bf00282515 · Cited by 16
Levine, R. F., & Haft, D. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007302830506 · Cited by 16
The role of the liver in the disposal of orally administered 14C-glucose in the normal rat
Jeffcoate, S. L., & Moody, A. J. (1969) · Diabetologia · doi:10.1007/bf00452901 · Cited by 16
Insulin and the Utilization of Carbohydrates in Obesity
Shreeve, W. W., Hoshi, M., Oji, N., Shigeta, Y., & Abe, H. (1968) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/21.12.1404 · Cited by 16
Growth hormone and insulin levels in newly discovered glucose intolerance
Sabeh, G., Corredor, D. G., Mendelsohn, L. V., Morgan, C. R., Sieracki, J. C., Sunder, J. H., Wingert, J. P., & Danowski, T. S. (1969) · Metabolism · doi:10.1016/0026-0495(69)90002-x · Cited by 16
Raposo, H. F., Vanzela, E. C., Berti, J. A., & Oliveira, H. C. F. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0179-6 · Cited by 15
Insulin secretion in health and disease: nutrients dictate the pace
Regazzi, R., Rodriguez‐Trejo, A., & Jacovetti, C. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115004152 · Cited by 17
Role and development of GLP-1 receptor agonists in the management of diabetes.
Chia, C. W., & Egan, J. M. (2009) · Europe PMC (PubMed Central) · Cited by 15
Patterson, J. T., Li, P., Day, J. W., Gelfanov, V. M., & DiMarchi, R. D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.01.003 · Cited by 15
Prasadan, K. L., Koizumi, M., Tulachan, S., Shiota, C., Lath, N. R., Paredes, J. L., Guo, P., El‐Gohary, Y., Malek, M. M., Shah, S. R., et al. (2011) · Diabetes · doi:10.2337/db09-0035 · Cited by 14
Incretins and the intensivist: what are they and what does an intensivist need to know about them?
Plummer, M. P., Chapman, M. J., Horowitz, M., & Deane, A. M. (2014) · Critical Care · doi:10.1186/cc13737 · Cited by 17
Diabetes - Damages and Treatments
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/1823 · Cited by 15
Bates, H. E., Sirek, A., Kiràly, M. A., Yue, J. T. Y., Riddell, M. C., Matthews, S. G., & Vranić, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90378.2008 · Cited by 15
Zawalich, W. S., & Zawalich, K. C. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660111 · Cited by 15
Metabolic handling of intraduodenal vs. intravenous glucose in humans
Féry, F., Deviere, J. M. E., & Balasse, E. O. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e261 · Cited by 15
Heterogeneity of insulin secretion in type II diabetes
Fajans, S. S. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610020308 · Cited by 15
Roges, O. A., Baron, M., & Philis‐Tsimikas, A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.705 · Cited by 15
Temporal characteristics of insulin: Glucose ratio after varying degrees of stress and trauma in man
Meguid, M. M., Aun, F., & Soeldner, J. S. (1978) · Journal of Surgical Research · doi:10.1016/s0022-4804(78)80002-x · Cited by 15
Insulin secretion in noninsulin-dependent Diabetes Mellitus
Broadstone, V. L., Ward, W. K., Beard, J., Best, J. D., Halter, J. B., Judzewitsch, R., Porte, D., & Pfeifer, R. (1986) · Springer eBooks · doi:10.1007/978-94-009-4301-8_6 · Cited by 15
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Soley, M., Chieri, R., Llobera, M., & Herrera, E. (1985) · International Journal of Biochemistry · doi:10.1016/0020-711x(85)90365-9 · Cited by 15
Rosselin, G., Claude, J., Eschwège, É., Patois, E., Warnet, J., & Richard, J. L. (1971) · Diabetologia · doi:10.1007/bf02346252 · Cited by 15
Taste Stimuli and Pancreatic Functions
Naim, M., & Kare, M. R. (1977) · Elsevier eBooks · doi:10.1016/b978-0-12-397850-9.50014-2 · Cited by 15
Augmentation of Insulin Secretion by a Non-Nutrient Drink
Goldberg, N. J., Wingert, T. D., Levin, S. R., & Adachi, R. I. (1980) · Gastroenterology · doi:10.1016/s0016-5085(19)30501-3 · Cited by 15
Sun, X., Ji, G., Li, P., Li, W., Li, J., & Zhu, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.695164 · Cited by 14
Incretin hormones and beta cell function in chronic pancreatitis.
Knop, F. K. (2010) · PubMed · Cited by 14
Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion
Zhang, H., Li, J., Liang, X., Luo, Y., Zen, K., & Zhang, C. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0114 · Cited by 14
INSULIN SECRETION AFTER TOLBUTAMIDE AND AFTER SECRETIN IN PATIENTS WITH PANCREATIC DISEASES
Deckert, T., Kølendorf, K., Persson, I., & WORNING, H. (1972) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1972.tb04847.x · Cited by 14
The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity
Mahler, R. J. (1981) · Acta Diabetologica · doi:10.1007/bf02056101 · Cited by 14
The expanding clinical use of C-peptide radioimmunoassay
Rendell, M. (1983) · Acta Diabetologica · doi:10.1007/bf02624911 · Cited by 15
Groop, P. (1989) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518909089110 · Cited by 14
Burr, I. M., TAFT, H. P., Stauffacher, W., & Renold, A. E. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb45253.x · Cited by 14
Insulin Secretion in Diabetes Mellitus
Cerasi, E. (1988) · Springer eBooks · doi:10.1007/978-3-642-72691-0_11 · Cited by 14
Hinke, S. A., Lynn, F. C., Ehses, J. A., Pamir, N., Manhart, S., Kühn‐Wache, K., Rosche, F., Demuth, H.-U., Pederson, R. A., & McIntosh, C. H. S. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47920-6_35 · Cited by 14
Fleischmajer, R., & Faludi, G. (1969) · Journal of Investigative Dermatology · doi:10.1038/jid.1969.53 · Cited by 14
Cardiovascular effects of GLP-1 receptor agonism
Winquist, R. J., & Gribkoff, V. K. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2022.02.005 · Cited by 14
Colonic L-cell impairment in aged subjects with type 2 diabetes leads to diminished GLP-1 production
Wang, Q., Zhang, W., Zhao, Y., Chen, H.-L., Liu, Q., Wang, Z., Zeng, L.-T., Li, J., Chen, S., Wei, L., et al. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102907 · Cited by 13
Ma, J., & Vella, A. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00324 · Cited by 14
4 Nutrients as regulators of endocrine and neuroendocrine secretion
Best, L. C., & McLaughlin, J. T. (2004) · Topics in current genetics · doi:10.1007/978-3-540-39898-1_5 · Cited by 13
Neuropeptides in the Control of the Islets of Langerhans
Wood, S. M., Polak, J. M., & Bloom, S. R. (1983) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027310-2.50021-9 · Cited by 13
Wu, L., Nicholson, W., Wu, C.-Y., Xu, M., McGaha, A., Shiota, M., & Powers, A. C. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302055 · Cited by 13
Spellacy, W. N., Buhi, W. C., Birk, S. A., & McCreary, S. A. (1971) · Fertility and Sterility · doi:10.1016/s0015-0282(16)38160-2 · Cited by 13
Lin, P., & Borer, K. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165378 · Cited by 13
Incretin Physiology and Pharmacology in the Intensive Care Unit
Plummer, M. P., Hermanides, J., & Deane, A. M. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.011 · Cited by 12
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff, A., & Müller, T. D. (2024) · Physiology · doi:10.1152/physiol.00032.2023 · Cited by 13
Chen, C., & Sibley, E. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00314.2011 · Cited by 12
Rebirth of the Incretin Concept: Its conception and early development
Marks, V. (2017) · Peptides · doi:10.1016/j.peptides.2017.08.002 · Cited by 12
RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes
Gault, V. A. (2017) · Diabetic Medicine · doi:10.1111/dme.13522 · Cited by 12
The Enteroendocrine System in Obesity
Miedzybrodzka, E. L., Reimann, F. M., & Gribble, F. M. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_582 · Cited by 12
Pathophysiology of Insulin Secretion in Diabetes Mellitus
Ward, W. K., Beard, J. C., Halter, J. B., & Porte, D. (1985) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-1850-8_9 · Cited by 12
Early-phase insulin secretion is disturbed in obese subjects with glucose intolerance
Mizuno, A., Arai, H., Fukaya, M., Sato, M., Yamanaka-Okumura, H., Takeda, E., & Doi, T. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.017 · Cited by 12
Olefsky, J. M., Batchelder, T., Farquhar, J. W., & Reaven, G. M. (1973) · Metabolism · doi:10.1016/0026-0495(73)90273-4 · Cited by 11
The Pathogenesis of Pancreatic Islet Cell Hyperplasia and Insulin Insensitivity in Obesity
Mahler, R. J. (1974) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027307-2.50016-5 · Cited by 12
Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance
Arii, K., Ota, K., Suehiro, T., Ikeda, Y., Nishimura, K., Kumon, Y., & Hashimoto, K. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.01.004 · Cited by 15
The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
Åhrén, B., Yamada, Y., & Seino, Y. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz036 · Cited by 11
Development of innovative tools for investigation of nutrient-gut interaction
Huang, W., Xie, C., Young, R. L., Zhao, J., Ebendorff‐Heidepriem, H., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i25.3562 · Cited by 11
Henquin, J. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154821 · Cited by 13
Shuang, J., Zhang, Y., Ma, L., TAN, X., Huang, J., Wang, X., Xiong, G., Jiang, Z., Zhang, X., DU, S., et al. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2669 · Cited by 11
Liu, X., Zhang, L., Feng, Y., Zhang, L. J., Qu, H. Y., Cao, G.-Q., & Leng, Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.75 · Cited by 11
Normalization of Insulin Delivery to Diabetics by Pulsed Insulin Infusion
Martin, P. J., & GENUTH, S. M. (1977) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.1977.326114 · Cited by 11
Dupré, J., Behme, M. T., HRAMIAK, I. M., & Longo, C. (1993) · Metabolism · doi:10.1016/0026-0495(93)90001-5 · Cited by 11
GIP and Insulin Responses to a Test Meal in Healthy and Obese Subjects
Jorde, R., Amland, P. F., BURHOL, P. G., Giercksky, K. E., & Ebert, R. (1983) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528309181850 · Cited by 11
Johansen, K. (1973) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1973.tb19424.x · Cited by 11
Insulin Sensitivity of Forearm Tissues in Prediabetic Man
Pozefsky, T., Santis, M. R., Soeldner, J. S., & Tancredi, R. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107338 · Cited by 11
Fat cell function and insulin in a patient with generalized lipodystrophy
Senior, B., & Loridan, L. (1969) · The Journal of Pediatrics · doi:10.1016/s0022-3476(69)80237-4 · Cited by 11
Type III hyperlipoproteinemia with low plasma thyroxine binding globulin
Dyerberg, J. (1969) · Metabolism · doi:10.1016/0026-0495(69)90132-2 · Cited by 11
GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
Li, S., Huang, N., Wang, M., Huang, W., Luo, Y., & Huang, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610512 · Cited by 12
Ahmadi, A., Huda, M. N., Bennett, B. J., Gamboa, J. L., Zelnick, L. R., Smith, L., Chondronikola, M., Raftery, D., de Boer, I. H., & Roshanravan, B. (2022) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2022.09.013 · Cited by 10
Cases, A. (2023) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2023.09.003 · Cited by 11
Subramanian, V., Bagger, J. I., Harihar, V., Holst, J. J., Knop, F. K., & Villsbøll, T. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2023 · Cited by 11
STOLAR, M. W., Chen, S., & Grimm, M. F. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s48837 · Cited by 10
Postprandial increase in glucagon-like peptide-1 is blunted in severe heart failure
Arruda-Junior, D. F., Martins, F. L., Salles, T. A., Jensen, L., Dariolli, R., Antônio, E. L., dos SANTOS, L., Crajoinas, R. O., Tucci, P. J. F., Gowdak, L. H. W., et al. (2020) · Clinical Science · doi:10.1042/cs20190946 · Cited by 10
HIROYOSHI, M., Tateishi, K., Yasunami, Y., Maeshiro, K., Ono, J., Matsuoka, Y., & Ikeda, S. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00098-2 · Cited by 10
Exacerbation of Diabetes Mellitus by Antibodies to Exogenous Insulin
Rendell, M., Hamilton, R. G., Drew, H. M., & Adkinson, N. F. (1981) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198107000-00003 · Cited by 10
Hyperglycemia and Glucagon Suppression: Possible Importance of the Vagus and Enteric Humoral Factors
Findlay, D. M., Omond, S. A., ALFORD, F. P., & Donald, J. A. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-1-13 · Cited by 10
VIII—INSULIN AND GLUCOSE HOMŒOSTASIS
Catt, K. J. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92885-0 · Cited by 10
Insulin analogues: New therapies for type 2 diabetes mellitus
Bethel, M. A., & Feinglos, M. N. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0104-4 · Cited by 10
Felber, J. P., Meyer, H. U., Curchod, B., Iselin, H. U., Rousselle, J., Maeder, E., Pahud, P., & Jéquier, E. (1981) · Diabetologia · doi:10.1007/bf01789111 · Cited by 10
Diminished gastrointestinal potentiation of insulin secretion in human pregnancy
HORNNES, P. J., K�hl, C., & Klebe, J. G. (1978) · Diabetologia · doi:10.1007/bf00421233 · Cited by 10
Glucokinase activity in isolated islets from obese fa/fa Zucker rats
Chan, C. B. (1993) · Biochemical Journal · doi:10.1042/bj2950673 · Cited by 10
Intestinal Nutrient Influence on the Enteroinsular Axis*
Miller, L. J., Malagelada, J., & Go, V. L. W. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-5-1009 · Cited by 10
Beta-cell secretory defect caused by mutations in glucokinase gene
Page, R. C., Hattersley, A. T., Turner, R. C., Velho, G., Clément, K., Pueyo, M. E., & Froguel, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)93192-p · Cited by 10
Lack of gastrointestinal enhancement of the insulin response to glucose in newborn infants
King, K. C., Schwartz, R., Yamaguchi, K., & Adam, P. A. J. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)81042-1 · Cited by 10
Insulin response to tolbutamide-glucose load in normal and diabetic subjects.
Ohneda, A., SATO, M., & Yamagata, S. (1974) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.114.171 · Cited by 10
Spellacy, W. N., Buhi, W. C., Birk, S. A., & McCreary, S. A. (1971) · Fertility and Sterility · doi:10.1016/s0015-0282(16)38161-4 · Cited by 10
Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging
Azad, B. B., Rota, V., Yu, L., McGirr, R., Amant, A. H. S., Lee, T.-Y., Dhanvantari, S., & Luyt, L. G. (2015) · Molecular Imaging · doi:10.2310/7290.2014.00057 · Cited by 10
Glycaemic management of type 2 diabetes
Kela, R., Srinivasan, B., & Davies, M. J. (2010) · Medicine · doi:10.1016/j.mpmed.2010.08.006 · Cited by 10
GLP-1 signaling and the regulation of pancreatic β-cells mass/function
Buteau, J. (2011) · Avances en Diabetología · doi:10.1016/s1134-3230(11)70002-3 · Cited by 10
Main Organs Involved in Glucose Metabolism
Lema-Pérez, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94585 · Cited by 12
NIDDM in the Cat: Treatment with the Oral Hypoglycemic Medication, Glipizide
Ford, S. L. (1995) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(95)50056-7 · Cited by 9
Type II Diabetes: Search for Primary Defects
Turner, R. C., Hattersley, A. T., & Cook, J. T. E. (1992) · Annals of Medicine · doi:10.3109/07853899209167004 · Cited by 9
Network Identification of Hormonal Regulation
Vis, D. J., Westerhuis, J. A., Hoefsloot, H. C. J., Roelfsema, F., van der Greef, J., Hendriks, M. M. W. B., & Smilde, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096284 · Cited by 9
Amland, P. F., Jorde, R., BURHOL, P. G., & Giercksky, K. E. (1985) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528509091656 · Cited by 9
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch10 · Cited by 11
Zhang, B., Saku, K., & Arakawa, K. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90253-5 · Cited by 9
Shuster, L. T., GO, V. L. W., Rizza, R. A., O’Brien, P. C., & Service, F. J. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62359-3 · Cited by 9
Umapathysivam, M. M., Araldi, E., Hastoy, B., Dawed, A. Y., Vatandaslar, H., Sengupta, S., Kaufmann, A., Thomsen, S., Hartmann, B., Jonsson, A. E., et al. (2023) · medRxiv · doi:10.1101/2023.04.07.23288197 · Cited by 9
Dedov, I. I., Yashkov, Y. I., & Ershova, E. V. (2012) · Obesity and metabolism · doi:10.14341/omet201223-10 · Cited by 8
Glucose Metabolism in Critically Ill Patients
Nielsen, S. T., Krogh‐Madsen, R., & Møller, K. (2013) · Journal of Intensive Care Medicine · doi:10.1177/0885066613503291 · Cited by 8
Metadata
- Authors
- Perley, M. J., & Kipnis, D. M.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1967-12-01
- Volume
- 46
- Issue
- 12
- Pages
- 1954-1962
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC292948
- OpenAlex
- W2169558934
- Cited by
- 917
- References
- 24
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 15 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 15 · 2017: 15 · 2016: 28 · 2015: 33 · 2014: 13 · 2013: 25 · 2012: 16
- FWCI
- 60.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin secretion, oral glucose tolerance, intravenous glucose, obesity, type 2 diabetes, hypersecretion, insulin resistance
- MeSH terms
- Adolescent, Adult, Aged, Arteries, Capillaries, Child, Diabetes Mellitus, Glucose, Humans, Infusions, Parenteral, Insulin, Middle Aged, Obesity, Veins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review